GlassScriptPhysician profile
Karri G Trivett
NPI 1699249060
$5,896.99
in general payments reported to CMS, 2019-2025
35 companies · $621 in 2025
The $621 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,012 · 2022: $1,199 · 2023: $1,540 · 2024: $1,524 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,576 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,575.64 |
| Education | $109.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $817.60 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $759.74 | 2021-2025 | |
| Glaxosmithkline, LLC. | $553.27 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $456.17 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $419.47 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $374.81 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $325.33 | 2021-2025 | Xifaxan |
| Amgen INC. | $257.58 | 2022-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $238.28 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $233.19 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $157.89 | 2021-2024 | Spravato, Xarelto |
| Novartis Pharmaceuticals Corporation | $135.12 | 2021-2023 | |
| Astellas Pharma US INC | $117.75 | 2022-2023 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $106.85 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $99.68 | 2021-2025 | Camzyos, Eliquis |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $96.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.19 | 2023-2024 | Synjardy, Jardiance |
| Mylan Specialty L.P. | $95.91 | 2021-2024 | Yupelri |
| Amarin Pharma, INC. | $78.16 | 2021 | |
| Bausch Health US, LLC | $64.10 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.18 | 2021-2024 | Trintellix |
| Merck Sharp & Dohme LLC | $50.18 | 2021-2024 | Gardasil 9, Gardasil, Capvaxive |
| Idorsia Pharmaceuticals US INC | $46.55 | 2022-2023 | Quviviq |
| Antares Pharma, INC. | $30.49 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Sanofi-Aventis U.S. LLC | $28.50 | 2021-2022 | |
| Ossur Americas, INC. | $25.71 | 2025 | |
| Esperion Therapeutics, INC. | $25.43 | 2021 | |
| Corcept Therapeutics | $24.73 | 2024 | Korlym |
| Lundbeck LLC | $22.67 | 2024 | Rexulti |
| Dexcom, INC. | $22.34 | 2025 | Dexcom G6 Transmitter |
| Alnylam Pharmaceuticals INC. | $18.17 | 2024 | Givlaari |
| Inogen, INC. | $16.46 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.41 | 2024 | Strensiq |
| Halozyme INC | $15.36 | 2023 | |
| Phathom Pharmaceuticals, INC. | $11.18 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karri Trivett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.